The diagnosis and management of migraine;Diagnostik und moderne Therapie der Migräne

Deutsches Arzteblatt

Volumn 103, Issue 17, 2006, Pages

  May, Arne ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Aura; Diagnosis; Guideline; Management; Migraine

Indexed keywords

ALMOTRIPTAN; ANALGESIC AGENT; BISOPROLOL; DICLOFENAC; DOMPERIDONE; ELETRIPTAN; FLUNARIZINE; FROVATRIPTAN; IBUPROFEN; METOCLOPRAMIDE; METOPROLOL; NAPROXEN; NARATRIPTAN; PARACETAMOL; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; VALPROIC ACID; ZOLMITRIPTAN;

BEHAVIOR THERAPY; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; GERMANY; HEADACHE; HUMAN; MEDICAL SOCIETY; MIGRAINE; MIGRAINE WITH AURA; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TENSION HEADACHE; TRANSFORMED MIGRAINE; TREATMENT INDICATION; VOMITING;

EID: 33646170876     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Diener H: Therapie der Migräneattacke und Migräneprophylaxe. In: Diener HC, Hrsg.: Leitlinien fr̈ Diagnostik und Therapie in der Neurologie. New York: Thieme Verlag 2005; 494-507.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl 1): 1-160.
3. Evers S, Pothmann R, Überall M, Naumann E, Gerber W: Therapie idiopathischer Kopfschmerzen im Kindesalter. Nervenheilkunde 2001; 20: 306-15.
4. Airy H: On a distinct form of transient hemianopsia. Philos Trans R Soc Lond B Biol Sci 1870; 160: 247-64.
5. Kelman L: The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004; 24(9): 728-34.
6. Winner P, Wasiewski W, Gladstein J, Linder S: Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache. Headache 1997; 37(9): 545-8.
7. Evans RW, Lipton RB, Silberstein SD: The prevalence of migraine in neurologists. Neurology 2003; 61(9): 1271-2.
8. Lanteri-Minet M, Radat F, Chautard MH, Lucas C: Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 2005; 118(3): 319-26.
9. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM et al.: Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005; 64(6): 1020-6.
10. Leniger T, von den Driesch S, Isbruch K, Diener H, Hufnagel A: Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 2003; 43: 672-7.
11. May A, Straube A, Peikert A, Diener H: Diagnostik und apparative Zusatzuntersuchungen bei Kopfschmerzen. In: Diener H, Hrsg.: Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Thieme Verlag 2005; 476-9.
12. Sandrini G, Friberg L, Janig W, Jensen R, Russell D, Sanchez del Rio M et al.: Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations. Eur J Neurol 2004; 11(4): 217-24.
13. Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ: Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: A multicentre, randomised, double-Blind, placebo-controlled comparison. Eur Neurol 2002; 47(2): 99-107.
14. Diener H, Limmroth V, May A: Neues bei Kopfschmerzen 2004. Aktuelle Neurologie 2004; 31: 425-34.
15. Visser WH, de Vriend RH, Jaspers NH, Ferrari MD: Sumatriptan-nonresponders: a survey in 366 migraine patients. Headache 1996; 36(8): 471-5.
16. Burstein R, Collins B, Jakubowski M: Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55(1): 19-26.
17. The subcutaneous sumatriptan international study group: Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-21.
18. Diener HC, for the ASASUMAMIG Study Group: Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 1999; 19: 581-8.
19. Leniger T, Pageler L, Stude P, Diener HC, Limmroth V: Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache 2005; 45(1): 42-6.
20. Leinisch E, Evers S, Kaempfe N, Kraemer C, Sostak P, Jurgens T et al.: Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain 2005; 117 (3): 396-400.
21. Rozen TD: Migraine Headache: Immunosuppressant therapy. Curr Treat Options Neurol 2002; 4(5): 395-01.
22. Diener HC, Rahlfs VW, Danesch U: The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004; 51(2): 89-97.
23. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH: Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005; 25 (11): 1031-41.
24. Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C et al.: Acupuncture for patients with migraine: a randomized controlled trial. Jama 2005; 293(17):2118-25.
25. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V: Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25(1): 12-5.
26. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V: Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57: 1694-8.